Rational computational Design of new-Generation EGFR tyrosine kinase (EGFR-TK) inhibitors
A library of 45 novel compounds, derivatives of 2,3-diphenyl-2,3-dihydro-1H-quinazolin-4-one, were designed as potential EGFR inhibitors. This work describes in-silico study utilizing structure-based drug design (SBDD) and ligand-based drug design (LBDD) methodologies, incorporating Absorption, Dist...
Saved in:
| Main Authors: | Chandraprakash Gond, Nikhil Kumar, Akanksha Mishra, Shivani Daksh, Anupama Datta, Anjani Kumar Tiwari |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Results in Chemistry |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S221171562500222X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring novel ligands for mGluR5: Design, computational analysis, and protein-ligand interaction studies
by: Chandraprakash Gond, et al.
Published: (2024-12-01) -
Exploring the binding dynamics of anticancer Dihydropyrimidinone derivatives with Serum Albumin: A multispectral approach
by: Chandraprakash Gond, et al.
Published: (2025-06-01) -
Combination Therapy With MET Tyrosine Kinase Inhibitor and EGFR Tyrosine Kinase Inhibitor in Patients With MET-Overexpressed EGFR-Mutant Lung Adenocarcinoma
by: Jia-Jun Wu, MD, et al.
Published: (2025-06-01) -
Discovery of BBT-176 as a fourth-generation EGFR tyrosine kinase inhibitor
by: Krishna Babu Duggirala, et al.
Published: (2025-07-01) -
Identification and selection of potential TNF-α inhibitors as anti-encephalitis candidates by using in silico assisted drug design
by: Pawan Kumar Gupta, et al.
Published: (2025-06-01)